Origen de la red de primer grado Stephan Jenn.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
NovAliX SAS
 NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France.
2
| Holding Company | Biotechnology | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Stephan Jenn a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Urania Therapeutics SAS
 Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Biotechnology | Director/Board Member Founder |
Estadísticas
Internacional
| Francia | 2 |
Sectorial
| Health Technology | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Denis Zeyer | 2 |
| Jean-Paul Renaud | 2 |
- Bolsa de valores
- Insiders
- Stephan Jenn
- Conexiones Empresas
